Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Trilostane treatment led to full hair regrowth in most Pomeranians and all miniature poodles with alopecia X.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Both creams are equally safe, but hydrocortisone may cause more visible blood vessels.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Combining laser treatment with steroid cream is more effective for alopecia areata than using the cream alone.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Triamcinolone regrows hair better but relapses more than anthralin.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Dexamethasone helps wound healing in septic mice but delays it in normal mice.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Most dogs with adrenal-dependent hypercortisolism had normal blood pressure after one year of treatment or surgery.

JAK inhibitors show promise in treating difficult skin diseases.